Fundamental Analysis
85 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +71.9% | +57.1% | 2 / 3 | +14.8% | +4.36 pp | +11.11 pp | +19.3% | 0.04 | 13.81 | 104 | +14,8% | 34,8 | +71,9% | 13.81 | 18.21 | −24,1% |
| Pts | 12 | 12 | 8 | 4 | 12 | 12 | 8 | 12 | 12 | |||||||
Valuation annotation:Price: 32.000 (close price on 2026-10-16)EPS (TTM): 2.317
Financial charts
1.Revenue & growth
VND bn104Q2/26
1.Revenue & growth
VND bn104Q2/26
2.Profit & growth
VND bn34,7Q2/26
3.Profit mix (Penman)
VND bn124Q2/26
4.Margins & cost structure
%35.4%Q2/26
5.Returns & cash cycle
% · days12.4%Q2/26
6.Earnings quality & cash
VND bn79,1Q2/26
7.Asset structure
VND bn692Q2/26
8.Funding & debt health
VND bn · times692Q2/26
9.Revenue backlog
VND bn0,12Q2/26
10.Valuation
times · %13,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %693Q2/26
Adjusted EPS growth, latest quarter
71.5%
Average adjusted EPS growth, 3 quarters
57.0%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26